Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kau

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 4, 2000
Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumorsK Hesse, B Heinrich, F Zimmermann, et al.
Oncology|March 1, 1997
Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I studyT Schilling, B Heinrich, R Kau, et al.
Seminars in Oncology|December 1, 1995
Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinomaA R Hanauske, T Schilling, B Heinrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neckF Thödtmann, F Theiss, M Kemmerich, et al.
Cancer Cell|January 7, 2004
A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cellsTweeny R Kau, Frank Schroeder, Shivapriya Ramaswamy, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 4, 2000
Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumorsK Hesse, B Heinrich, F Zimmermann, et al.
Oncology|March 1, 1997
Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I studyT Schilling, B Heinrich, R Kau, et al.
Seminars in Oncology|December 1, 1995
Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinomaA R Hanauske, T Schilling, B Heinrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neckF Thödtmann, F Theiss, M Kemmerich, et al.
Cancer Cell|January 7, 2004
A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cellsTweeny R Kau, Frank Schroeder, Shivapriya Ramaswamy, et al.
Pageof 2